ROTHSCHILD & CO ASSET MANAGEMENT US INC. – Halozyme Therapeutics, Inc. Transaction History
ROTHSCHILD & CO ASSET MANAGEMENT US INC. portfolio value:
$7.22M
portfolio value
ROTHSCHILD & CO ASSET MANAGEMENT US INC. quarter portfolio value change:
-10.14%
quarter
Halozyme Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.59% | -1.08K shares | -863K | $39.54 | 182.68K |
| Q2 2022 | share | Decrease | -0.26% | -484 shares | 738K | $44 | 183.77K |
| Q1 2022 | share | Decrease | -19.55% | -44.76K shares | -1.86M | $39.88 | 184.25K |
| Q4 2021 | share | Increase | 0.00% | 229.02K shares | 9.20M | $40.32 | 229.02K |